Protalix BioTherapeutics, Inc. Operating Cash Flow
Protalix BioTherapeutics, Inc. (PLX) reported Operating Cash Flow of $11.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-12
- Protalix BioTherapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$10.40M.
- Protalix BioTherapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $22.02M.
- Protalix BioTherapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $2.03M, a 49.14% decline year-over-year.
- Protalix BioTherapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.73M, a 190.91% decline year-over-year.
- Protalix BioTherapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$11.99M, a 238.26% decline from fiscal 2024.
- Protalix BioTherapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $8.67M.
- Protalix BioTherapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$1.32M.
- Protalix BioTherapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$25.00M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$10.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $11.63M 10-Q · filed 2026-08-12 | $13.65M derived: sum of 3 quarters · filed 2026-08-12 | $9.92M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $22.02M 10-Q · filed 2026-05-13 | $24.05M derived: sum of 2 quarters · filed 2026-05-13 | $20.32M derived: sum of 3 quarters · filed 2026-05-13 | $15.09M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$1.70M derived: sum of 2 quarters · filed 2026-03-18 | -$6.93M derived: sum of 3 quarters · filed 2026-08-12 | -$11.99M 10-K · filed 2026-03-18 |
| 2025-09-30 | -$3.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$8.96M derived: sum of 2 quarters · filed 2026-08-12 | -$14.02M 10-Q · filed 2025-11-13 | -$10.03M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$5.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$10.29M 10-Q · filed 2026-08-12 | -$6.30M derived: sum of 3 quarters · filed 2026-08-12 | -$2.19M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$5.06M 10-Q · filed 2026-05-13 | -$1.07M derived: sum of 2 quarters · filed 2026-05-13 | $3.04M derived: sum of 3 quarters · filed 2026-05-13 | -$572.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $3.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $8.10M derived: sum of 2 quarters · filed 2026-03-18 | $4.49M derived: sum of 3 quarters · filed 2026-03-18 | $8.67M 10-K · filed 2026-03-18 |
| 2024-09-30 | $4.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $495.00K derived: sum of 2 quarters · filed 2025-11-13 | $4.68M 10-Q · filed 2025-11-13 | $8.28M derived: sum of 4 quarters · filed 2026-03-18 |
| 2024-06-30 | -$3.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $578.00K 10-Q · filed 2025-08-14 | $4.17M derived: sum of 3 quarters · filed 2026-03-18 | -$2.71M derived: sum of 4 quarters · filed 2026-03-18 |
| 2024-03-31 | $4.19M 10-Q · filed 2025-05-09 | $7.78M derived: sum of 2 quarters · filed 2026-03-18 | $895.00K derived: sum of 3 quarters · filed 2026-03-18 | $5.87M derived: sum of 4 quarters · filed 2026-03-18 |
| 2023-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$3.29M derived: sum of 2 quarters · filed 2026-03-18 | $1.68M derived: sum of 3 quarters · filed 2026-03-18 | -$1.32M 10-K · filed 2026-03-18 |
| 2023-09-30 | -$6.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.92M derived: sum of 2 quarters · filed 2024-11-14 | -$4.91M 10-Q · filed 2024-11-14 | -$7.52M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $4.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.98M 10-Q · filed 2024-08-14 | -$636.00K derived: sum of 3 quarters · filed 2025-03-17 | -$9.84M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | -$3.00M 10-Q · filed 2024-05-10 | -$5.61M derived: sum of 2 quarters · filed 2025-03-17 | -$14.81M derived: sum of 3 quarters · filed 2025-03-17 | -$22.17M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | -$2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$11.81M derived: sum of 2 quarters · filed 2025-03-17 | -$19.17M derived: sum of 3 quarters · filed 2025-03-17 | -$25.00M 10-K · filed 2025-03-17 |
| 2022-09-30 | -$9.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$16.56M derived: sum of 2 quarters · filed 2023-11-06 | -$22.39M 10-Q · filed 2023-11-06 | -$27.48M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | -$7.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$13.19M 10-Q · filed 2023-08-07 | -$18.27M derived: sum of 3 quarters · filed 2024-03-14 | -$20.15M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | -$5.83M 10-Q · filed 2023-05-04 | -$10.92M derived: sum of 2 quarters · filed 2024-03-14 | -$12.80M derived: sum of 3 quarters · filed 2024-03-14 | -$6.28M derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | -$5.09M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$6.97M derived: sum of 2 quarters · filed 2024-03-14 | -$451.00K derived: sum of 3 quarters · filed 2024-03-14 | -$10.29M 10-K · filed 2024-03-14 |
| 2021-09-30 | -$1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $4.64M derived: sum of 2 quarters · filed 2022-11-14 | -$5.20M 10-Q · filed 2022-11-14 | -$12.75M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $6.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$3.32M 10-Q · filed 2022-08-15 | -$10.87M derived: sum of 3 quarters · filed 2023-02-27 | -$14.47M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | -$9.83M 10-Q · filed 2022-05-16 | -$17.38M derived: sum of 2 quarters · filed 2023-02-27 | -$20.99M derived: sum of 3 quarters · filed 2023-02-27 | -$28.82M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$7.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$11.15M derived: sum of 2 quarters · filed 2023-02-27 | -$18.99M derived: sum of 3 quarters · filed 2023-02-27 | -$26.11M 10-K · filed 2023-02-27 |
| 2020-09-30 | -$3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$11.44M derived: sum of 2 quarters · filed 2021-11-15 | -$18.56M 10-Q · filed 2021-11-15 | -$22.24M derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-06-30 | -$7.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$14.95M 10-Q · filed 2021-08-16 | -$18.64M derived: sum of 3 quarters · filed 2022-03-31 | -$21.86M derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-03-31 | -$7.12M 10-Q · filed 2021-05-14 | -$10.80M derived: sum of 2 quarters · filed 2022-03-31 | -$14.03M derived: sum of 3 quarters · filed 2022-03-31 | -$19.20M derived: sum of 4 quarters · filed 2022-03-31 |
| 2019-12-31 | -$3.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$6.91M derived: sum of 2 quarters · filed 2022-03-31 | -$12.08M derived: sum of 3 quarters · filed 2022-03-31 | -$19.36M 10-K · filed 2022-03-31 |
| 2019-09-30 | -$3.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$8.39M derived: sum of 2 quarters · filed 2020-10-29 | -$15.67M 10-Q · filed 2020-10-29 | -$19.68M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-06-30 | -$5.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$12.45M 10-Q · filed 2020-08-10 | -$16.45M derived: sum of 3 quarters · filed 2021-03-30 | -$2.81M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-03-31 | -$7.28M 10-Q · filed 2020-06-01 | -$11.28M derived: sum of 2 quarters · filed 2021-03-30 | $2.36M derived: sum of 3 quarters · filed 2021-03-30 | -$5.61M derived: sum of 4 quarters · filed 2021-03-30 |
| 2018-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $9.63M derived: sum of 2 quarters · filed 2021-03-30 | $1.67M derived: sum of 3 quarters · filed 2021-03-30 | -$7.74M 10-K · filed 2021-03-30 |
| 2018-09-30 | $13.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $5.67M derived: sum of 2 quarters · filed 2019-11-07 | -$3.74M 10-Q · filed 2019-11-07 | $13.85M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | -$7.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$17.38M 10-Q · filed 2019-08-08 | $213.00K derived: sum of 3 quarters · filed 2020-03-12 | -$10.33M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | -$9.41M 10-Q · filed 2019-05-06 | $8.18M derived: sum of 2 quarters · filed 2020-03-12 | -$2.36M derived: sum of 3 quarters · filed 2020-03-12 | -$10.98M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $17.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $7.05M derived: sum of 2 quarters · filed 2020-03-12 | -$1.57M derived: sum of 3 quarters · filed 2020-03-12 | -$9.99M 10-K · filed 2020-03-12 |
| 2017-09-30 | -$10.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-18 | -$19.16M derived: sum of 2 quarters · filed 2019-03-18 | -$27.58M 10-Q · filed 2019-03-18 | -$34.92M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | -$8.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-03-18 | -$17.05M 10-Q · filed 2019-03-18 | -$24.38M derived: sum of 3 quarters · filed 2019-03-18 | -$27.83M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | -$8.43M 10-Q · filed 2019-03-18 | -$15.76M derived: sum of 2 quarters · filed 2019-03-18 | -$19.21M derived: sum of 3 quarters · filed 2019-03-18 | -$30.90M derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | -$7.34M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$10.78M derived: sum of 2 quarters · filed 2019-03-18 | -$22.47M derived: sum of 3 quarters · filed 2019-03-18 | -$32.10M 10-K · filed 2019-03-18 |
| 2016-09-30 | -$3.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$15.13M derived: sum of 2 quarters · filed 2017-11-08 | -$24.76M 10-Q · filed 2017-11-08 | -$28.62M derived: sum of 4 quarters · filed 2018-03-06 |
| 2016-06-30 | -$11.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$21.32M 10-Q · filed 2017-08-09 | -$25.17M derived: sum of 3 quarters · filed 2018-03-06 | -$33.83M derived: sum of 4 quarters · filed 2018-03-06 |
| 2016-03-31 | -$9.63M 10-Q · filed 2017-05-10 | -$13.48M derived: sum of 2 quarters · filed 2018-03-06 | -$22.14M derived: sum of 3 quarters · filed 2018-03-06 | -$27.49M derived: sum of 4 quarters · filed 2018-03-06 |
| 2015-12-31 | -$3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | -$12.52M derived: sum of 2 quarters · filed 2018-03-06 | -$17.86M derived: sum of 3 quarters · filed 2018-03-06 | -$24.28M 10-K · filed 2018-03-06 |
| 2015-09-30 | -$8.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$14.01M derived: sum of 2 quarters · filed 2016-11-09 | -$20.43M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | -$5.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$11.77M 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | -$6.42M 10-Q · filed 2016-05-09 | |||
| 2014-12-31 | -$29.28M 10-K · filed 2017-03-16 | |||
| 2013-12-31 | -$4.74M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | -$12.96M derived: sum of 2 quarters · filed 2016-03-08 | -$21.07M derived: sum of 3 quarters · filed 2016-03-08 | -$30.65M 10-K · filed 2016-03-08 |
| 2013-09-30 | -$8.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$16.32M derived: sum of 2 quarters · filed 2013-11-07 | -$25.91M 10-Q · filed 2013-11-07 | -$24.09M derived: sum of 4 quarters · filed 2013-11-07 |
| 2013-06-30 | -$8.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$17.70M 10-Q · filed 2013-08-08 | -$15.87M derived: sum of 3 quarters · filed 2013-08-08 | -$23.90M derived: sum of 4 quarters · filed 2013-11-07 |
| 2013-03-31 | -$9.59M 10-Q · filed 2013-05-09 | -$7.76M derived: sum of 2 quarters · filed 2013-05-09 | -$15.79M derived: sum of 3 quarters · filed 2013-11-07 | -$2.67M derived: sum of 4 quarters · filed 2013-11-07 |
| 2012-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$6.21M derived: sum of 2 quarters · filed 2013-11-07 | $6.92M derived: sum of 3 quarters · filed 2013-11-07 | $635.00K 10-K · filed 2013-02-28 |
| 2012-09-30 | -$8.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $5.09M derived: sum of 2 quarters · filed 2013-11-07 | -$1.19M 10-Q · filed 2013-11-07 | -$7.80M derived: sum of 4 quarters · filed 2013-11-07 |
| 2012-06-30 | $13.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $6.84M 10-Q · filed 2013-08-08 | $231.00K derived: sum of 3 quarters · filed 2013-08-08 | -$7.92M derived: sum of 4 quarters · filed 2013-08-08 |
| 2012-03-31 | -$6.28M 10-Q · filed 2013-05-09 | -$12.89M derived: sum of 2 quarters · filed 2013-05-09 | -$21.04M derived: sum of 3 quarters · filed 2013-05-09 | -$25.86M derived: sum of 4 quarters · filed 2013-05-09 |
| 2011-12-31 | -$6.61M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$14.76M derived: sum of 2 quarters · filed 2013-02-28 | -$19.58M derived: sum of 3 quarters · filed 2013-02-28 | -$23.57M 10-K · filed 2013-02-28 |
| 2011-09-30 | -$8.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$12.97M derived: sum of 2 quarters · filed 2012-11-07 | -$16.96M 10-Q · filed 2012-11-07 | -$24.99M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | -$4.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | -$8.81M 10-Q · filed 2012-08-03 | -$16.84M derived: sum of 3 quarters · filed 2013-02-28 | -$26.52M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | -$3.99M 10-Q · filed 2012-05-09 | -$12.02M derived: sum of 2 quarters · filed 2013-02-28 | -$21.70M derived: sum of 3 quarters · filed 2013-02-28 | |
| 2010-12-31 | -$8.03M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$17.71M derived: sum of 2 quarters · filed 2013-02-28 | -$38.46M 10-K · filed 2013-02-28 | |
| 2010-09-30 | -$9.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$30.43M 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | -$20.75M 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | $44.45M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |